Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 2/20 | 0.49 |
| ▸ | FNTA | P49354 | 2/20 | 0.49 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.49 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | ULK1 | O75385 | 1/20 | 0.42 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.42 |
| ▸ | TACR1 | P25103 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
| ▸ | CPA1 | P15085 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL762665 | 0.82 | GHSR (0.71) | GHSR | |
| SCHEMBL3656798 | 0.82 | TDP1 (0.56) | FNTAPGGT1BMMP9HRH4MME | |
| SCHEMBL8671105 | 0.82 | TDP1 (0.56) | FNTAPGGT1BMMP9HRH4MME | |
| SCHEMBL761579 | 0.81 | F10 (0.52) | GHSRMMP9TACR1 | |
| SCHEMBL14527661 | 0.81 | PRSS1 (0.46) | GHSR | |
| SCHEMBL10054043 | 0.81 | CAPN1 (0.57) | MMP9 | |
| SCHEMBL8671980 | 0.80 | FNTA (0.56) | FNTAPGGT1BMMP9HRH4MME | |
| SCHEMBL8668244 | 0.79 | FNTA (0.55) | FNTAPGGT1BMMP9HRH4MME | |
| SCHEMBL762500 | 0.79 | GHSR (0.52) | GHSRFNTAPGGT1BMMP9HRH4 | |
| SCHEMBL739284 | 0.75 | GHSR (0.63) | GHSRFNTAPGGT1BMMP9TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138218-B2 | Growth hormone secretagogues | IPSEN PHARMA S.A.S. (FR) | 2012-03-20 | — | — | US | disclosed |
| US-20090131478-A1 | Growth Hormone Secretagogues | IPSEN PHARMA S.A.S. (FR) | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131478-A1 | Growth Hormone Secretagogues | GHSR, GHRHR, GHITM | GHSR 1/4885FNTA 2002/4885PGGT1B 397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.